Alessandro Fogliati

Dr. Alessandro Fogliati

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2024 in Pancreatology
Verified
Journal Article
Open access
AFAlessandro Fogliati
Alessandro Fogliati
SCStefano Crippa
Stefano Crippa
GMGiovanni Marchegiani
Giovanni Marchegiani
GBGiulio Belfiori
Giulio Belfiori
APAntonio Pea
Antonio Pea
MTMark J. Truty
Mark J. Truty
Mucinous cystic neoplasms (MCN) of the pancreas express estrogen and progesterone receptors. Several case reports describe MCN increasing in size during gestation. The aim of this study is to assess if pregnancy is a risk factor for malignant degeneration of MCN. All female patients who underwent pancreatic resection of a MCN between 2011 and 2021 were included. MCN resected or diagnosed within 12 months of gestation were defined perigestational. MCN with high grade dysplasia or an invasive component were classified in the high grade (HG) group. The primary outcome was defined as the correlation between exposure to gestation and peri-gestational MCN to development of HG-MCN. The study includes 176 patients, 25 (14 %) forming the HG group, and 151 (86 %) forming the low grade (LG) group. LG and HG groups had a similar distribution of systemic contraceptives use (26 % vs. 16 %, p = 0.262), and perigestational MCN (7 % vs 16 %, p = 0.108). At univariate analysis cyst size ≥10 cm (OR 5.3, p < 0.001) was associated to HG degeneration. Peri gestational MCN positively correlated with cyst size (R = 0.18, p = 0.020). In the subgroup of 14 perigestational MCN patients 29 % had HG-MCN and 71 % experienced cyst growth during gestation with an average growth of 55.1 ± 18 mm. Perigestational MCN are associated to increased cyst diameter, and in the subset of patients affected by MCN during gestation a high rate of growth was observed. Patients with a MCN and pregnancy desire should undergo multidisciplinary counselling.

9 December 2021 in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
Verified
Journal Article
Open access
AFAlessandro Fogliati
Alessandro Fogliati
Mattia GaranciniMattia Garancini
Mattia Garancini
FUFabio Uggeri
Fabio Uggeri
MBMarco Braga
Marco Braga
LGLuca Gianotti
Luca Gianotti
Background: Mucinous cystic neoplasms and solid pseudopapillary neoplasms are the most common pancreatic tumors occurring in women of fertile age and in pregnant women. The aim of this study is to provide an updated literature review on this association and to present a fully laparoscopic resection of a pregnancy-associated pancreatic cystic neoplasm. Materials and Methods: A systematic literature review was performed using PubMed (MEDLINE), Scopus, Ovid, ISI Web of Science, and Google Scholar for searching. The syntax was (pancr*) AND (cyst*) AND (pregn*) AND (tumor). Only English-language articles describing pancreatic surgical resections were included. Results: Forty-seven case reports were included. The mean age of the patients was 29.6±5.3. Nine patients (20%) required emergency surgery, 4 (9%) due to cyst rupture, and 5 (11%) due to hemorrhage. Four patients (9%) suffered a miscarriage, and 2 (5%) opted for pregnancy termination; the rest of the women delivered a healthy newborn (86%, n=36). Thirty percent (n=14) of the resected neoplasms were malignant, and among mucinous cystic lesions, this raised to 45% (n=11). All patients diagnosed during the third trimester were resected postpartum, whereas 26/34 (76%) of patients diagnosed during the first 2 trimesters underwent surgery before delivery. Conclusions: The most worrisome complications in pregnancy-associated pancreatic cysts are bleeding or rupture. Mucinous cystic neoplasm has a tendency to grow during pregnancy. A postpartum resection was generally preferred when the cystic neoplasm was diagnosed during the third trimester. This report is the first to describe a fully laparoscopic pancreatic resection.

24 April 2022 in Cureus
Verified
Journal Article
Open access
ARAgostino Roasio
Agostino Roasio
ECEleonora Costanzo
Eleonora Costanzo
GBGiorgio Bergesio
Giorgio Bergesio
SBSTEFANO BOSSO
STEFANO BOSSO
SLSandro Longu
Sandro Longu
MNMaria Teresa Novelli
Maria Teresa Novelli
Objective: During the coronavirus disease 2019 (COVID-19) pandemic a proactive rounding (PR) team was introduced in our clinical practice in order to recognize the clinical deterioration of the patient as soon as possible. This study aimed to evaluate the impact of the PR team on the rapid response system (RRS) workload with particular regard to the activity carried out, the mode of intervention, and the outcome of patients. Methods: In this retrospective study, the first period before the activation of the PR team (March 1, 2019, to February 29, 2020) and the second period after its activation (March 1, 2020, to March 1, 2021) were compared. Results: A total of 406 inpatient RRS activations were collected. The medical emergency team (MET) dose was 13 and 12.2 activations/1000 admitted patients per year while the incidence of unexpected cardiac arrests was 3.8 and 2.6 events/1000 admitted patients per year (p=0.10). MET response time was longer in the second period (3.5±1.6 minutes vs 4.5±2.6 minutes p<0.01). We recorded more RRS activations for medical patients than surgical ones; MET was activated more frequently by physicians than nurses and for less severe criteria. Patients admitted to the intensive care unit had lower Simplified Acute Physiology Score II (SAPS II) scores. Conclusions: The PR team introduced during the COVID-19 pandemic did not increase the RRS workload. In addition, it allowed an earlier activation of the MET, especially by physicians.

15 July 2024 in Livers
Verified
Journal Article
Open access
PDF file
FFFederica Ferraina
Federica Ferraina
AFAlessandro Fogliati
Alessandro Fogliati
MSMauro Alessandro Scotti
Mauro Alessandro Scotti
Fabrizio RomanoFabrizio Romano
Fabrizio Romano
MGMattia Garancini
Mattia Garancini
CCCristina Ciulli
Cristina Ciulli
Segmental or lobar liver atrophy is a common but not well-understood clinical condition. Hepatic atrophy can be classified into hepatic atrophy secondary to other pathologies and primary segmental hepatic atrophy, which is a benign intrahepatic lesion (pseudotumor) not associated with any other pathology. The pathophysiological mechanisms underlying atrophy can be divided into three main situations: obstruction of biliary outflow, obstruction of the systemic venous outflow, and obstruction of incoming portal venous flow. For what may concern secondary hepatic atrophy, there are many pathologies that could underlie this condition, ranging from benign to intrahepatic malignancies, with particular reference to particularly hepatocellular carcinoma and biliary duct carcinoma. An accurate and prompt differential diagnosis between the various forms and causes of atrophy is important for early identification and adequate treatment of underlying pathologies. A comprehensive review of the literature on the etiology and the radiological and histological characteristics of different types of hepatic atrophy is currently unavailable. Therefore, the aim of this review is to summarize the primary and secondary causes of segmental or lobar liver atrophy (excluding forms involving the entire liver parenchyma) and to provide practical tools for clinical and radiological differential diagnosis.

31 March 2022 in Pancreatology
Verified
Journal Article
Closed access
RVRoberto Valente
Roberto Valente
SCStefano Crippa
Stefano Crippa
UAUrban Arnelo
Urban Arnelo
GVGiuseppe Vanella
Giuseppe Vanella
GZGiulia Zerboni
Giulia Zerboni
MCMarco Del Chiaro
Marco Del Chiaro

13 December 2025 in Surgical Oncology
Verified
Journal Article
Closed access
GCGianluca Cassese
Gianluca Cassese
FPFabrizio Panaro
Fabrizio Panaro
FGFabio Giannone
Fabio Giannone
MAMariantonietta Alagia
Mariantonietta Alagia
MPMarco Palucci
Marco Palucci
FRFabrizio Romano
Fabrizio Romano